Maria DeSantis
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Surgery 5
- Testicular diseases and treatments 3
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Yves Boucher (1 shared paper)R K Jain (1 shared paper)Dragan Opačić (1 shared paper)John M. Kirkwood (1 shared paper)Michael Fiegl (2 shared papers)Heinz Ludwig (2 shared papers)Jutta Ackermann (2 shared papers)J. C. Schuster (2 shared papers)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (1 paper)Journal of Dermatological Treatment (1 paper)Cancer (1 paper)Seminars in Oncology (1 paper)
- Partner nations
- AustriaGermanyUnited Kingdom
In The Last Decade
Maria DeSantis
11 papers receiving 635 citations
Peers
Comparison fields: 5 of 66
- Hematology 203
- Oncology 202
- Otorhinolaryngology 31
- Pathology and Forensic Medicine 120
- Genetics 67
Countries citing papers authored by Maria DeSantis
This map shows the geographic impact of Maria DeSantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria DeSantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria DeSantis more than expected).
Fields of papers citing papers by Maria DeSantis
This network shows the impact of papers produced by Maria DeSantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria DeSantis. The network helps show where Maria DeSantis may publish in the future.
Co-authors
The 25 scholars most cited alongside Maria DeSantis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 239 | |
| 2 | Interstitial hypertension in superficial metastatic melanomas in humans. | 1991 | 178 |
| 3 | 2002 | 106 | |
| 4 | 2002 | 42 | |
| 5 | 1999 | 37 | |
| 6 | 2020 | 24 | |
| 7 | 1998 | 10 | |
| 8 | 2019 | 7 | |
| 9 | 2013 | 3 | |
| 10 | 1996 | 3 | |
| 11 | 2011 | 2 |
About Maria DeSantis
Maria DeSantis is a scholar working on Surgery, Molecular Biology, Oncology, Hematology and Reproductive Medicine, having authored 11 papers that have together received 651 indexed citations. Recurring topics across this work include Testicular diseases and treatments (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers), Sperm and Testicular Function (2 papers), Cancer-related Molecular Pathways (2 papers), Circadian rhythm and melatonin (1 paper), Head and Neck Cancer Studies (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Hematology (203 citations), Oncology (202 citations), Otorhinolaryngology (31 citations), Pathology and Forensic Medicine (120 citations) and Genetics (67 citations). Maria DeSantis has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include Yves Boucher, R K Jain, Dragan Opačić, John M. Kirkwood, Michael Fiegl, Heinz Ludwig, Jutta Ackermann, J. C. Schuster, Niklas Zojer and R. Roka. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Dermatological Treatment, Cancer and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.